A significant structural issue has emerged at a Manhattan high-rise under conversion from office to residential use, leading to evacuations and ongoing stabilization efforts. The building, formerly Pfizer's headquarters, experienced buckled columns and sagging floors primarily between the 18th and 23rd levels. Emergency crews worked overnight to stabilize the structure, and as of Wednesday, July 8, 2026, the building was deemed stable, with no further movement detected.
Despite the stabilization, four nearby buildings remain under evacuation orders, and adjacent streets are closed for safety. The city's Department of Buildings plans a comprehensive safety review before allowing further construction. The developer, MetroLoft, acknowledged structural strain from construction modifications but insists the building remains structurally sound. The renovation project is part of the largest office-to-residential conversion in New York City, aiming to deliver approximately 1,600 housing units.
Residents and hotel guests have been gradually allowed to return to the area, though some remain concerned about the handling of the incident. Protests erupted at the site, with union workers criticizing the developers for using non-union labor. Visitors affected by the evacuation, including Scottish tourists left without their belongings, expressed frustration over the incident.
The city's Department of Buildings is conducting a rigorous assessment to ensure compliance with all codes before any non-emergency work proceeds. The situation remains under close monitoring to ensure the safety of all involved.